profit from every $100 of sales.
$0$100
Concentra Group Holdings Parent
$42.55-1.02% today
+121.2% in 1 year
1-year low $19.231-year high $43.56
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $32.14 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Concentra Group Holdings Parent sold, what it kept, and what it did with the cash.
Sales went from $1.72 billion in 2022 to $2.16 billion in 2025, with $166 million of profit last year.
SalesProfit
Concentra Group Holdings Parent handed back 28% of the cash it generated last year.
Buybacks $22M$32M
Free cash flow 2025$197M
Bought back its own shares$22M
Paid as dividends$32M
Cash vs. debt$80M vs. $2.1B
Concentra Group Holdings Parent vs. similar companies
Concentra Group Holdings Parent grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Concentra Group Holdings Parent | 32.1× · Expensive | ||
 Hims & Hers Health | 36.0× · Expensive | ||
 Envista | 83.5× · Very expensive | ||
 Beta Bionics | No profit yet | ||
 CapsoVision | No profit yet |
AI analysis
An AI analyst reads Concentra Group Holdings Parent's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1,724 | 1,838 | 1,900 | 2,163 | |
| 482 | 512 | 528 | 613 | |
| 259 | 288 | 305 | 334 | |
| 330 | 360 | 368 | 409 | |
| 167 | 180 | 167 | 166 | |
| 1.32 | 1.42 | 1.46 | 1.30 | |
| 27.9% | 27.9% | 27.8% | 28.3% | |
| 15.0% | 15.6% | 16.0% | 15.4% | |
| 9.7% | 9.8% | 8.8% | 7.7% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2,297 | 2,334 | 2,521 | 2,858 |
| Cash | 38 | 31 | 183 | 80 |
| Total debt | 1,040 | 905 | 1,951 | 2,103 |
| Total liabilities | 1,301 | 1,156 | 2,222 | 2,438 |
| 0 | 0 | 276 | 393 | |
| 127 | 127 | 114 | 128 | |
| 19.5% | 25.1% | 10.7% | 10.5% | |
| – | – | 60.4% | 42.3% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 274 | 234 | 275 | 279 | |
| 46 | 69 | 64 | 82 | |
| 228 | 165 | 210 | 197 | |
| Dividends paid | 0 | 0 | 1,544 | 32 |
| 29 | 5 | 15 | 22 | |
| 2 | 1 | 2 | 10 |
Valuation
- 32.1×
- 29.2×
- –
- 7.4×
- 2.5×
- 27.1×
- 18.0×
- 3.7%
- 3.1%
- 1.0%
Profitability
- 28.3%
- 15.4%
- 7.7%
- 19.2%
- 60.7%
- 7.9%
- 46.0%
- 6.2%
- 81.9%
- –
Growth
- +7.9%
- −0.4%
- −6.3%
- –
- +0.0%
Financial health
- 4.8×
- 5.00
- 73.5%
- 19.2×
- 1.26
- 1.26
- 0.77
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 1%of 963
Top 36%of 894
Bottom 40%of 632
Bottom 41%of 908
Top 32%of 991
What analysts expect
- Average price target
- $31.00
- Range
- $31.00 – $31.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | 0.40 | 0.35 | +14.3% |
| Jan 28, 2026 | 0.28 | 0.23 | +23.5% |
| Nov 6, 2025 | 0.39 | 0.37 | +5.4% |
| Aug 7, 2025 | 0.37 | 0.37 | +0.0% |
| May 7, 2025 | 0.32 | 0.31 | +3.2% |
| Mar 3, 2025 | 0.17 | 0.16 | +6.3% |
| Oct 31, 2024 | 0.37 | 0.36 | +2.8% |
| Aug 1, 2024 | 0.50 | 0.49 | +2.0% |
1.0%of the share price, paid each year
On $1,000 invested$10a year at today's yield, before tax
–per share
Raised1 yearin a row, in our data
Paid per share, each year
$0.06 in 2024 → $0.25 in 2025
How safe it looks
19.3% of its profit
Room to growStretchedMore than it earns: 16.3%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
43No pass
Benjamin Graham
29No pass
Philip Fisher
36No pass
Peter Lynch
17No pass
Joel Greenblatt
59No pass
Charlie Munger
47No pass
Terry Smith
53No pass
Questions about Concentra Group Holdings Parent
Is Concentra Group Holdings Parent a good stock to buy?
A business with weak numbers, but the price is high. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Concentra Group Holdings Parent AI analysis
What does Concentra Group Holdings Parent do?
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. It is in Medical - Equipment & Services, based in Addison, TX, United States, with 9,967 employees.
Does Concentra Group Holdings Parent pay a dividend?
Yes. At today's price the dividend is 1.0% a year, about 19% of its yearly profit. In 2025 it paid out $32.1 million in dividends.
Is Concentra Group Holdings Parent stock halal?
No. Concentra Group Holdings Parent does not pass our halal screen: its debt is 39% of its market value, at or above the 33% limit. How we check
How has Concentra Group Holdings Parent stock done over the past year?
Up 121.2% over the past twelve months, to $42.55. It traded between $19.23 and $43.56 and is 2.3% below its high.
Who are Concentra Group Holdings Parent's competitors?
The largest listed companies in the same industry are Hims & Hers Health, Envista, Beta Bionics and CapsoVision. The peers table on this page compares their profit, growth and price with Concentra Group Holdings Parent's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.